Literature DB >> 11915012

Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans.

Michael A Rubin, Karen C Carroll, Barbara C Cahill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11915012     DOI： 10.1086/339755

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  13 in total

1.  What's New in Antifungals?

Authors:  John M. Valgus
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

Review 2.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

Review 3.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

Review 4.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Guillermo Garcia-Effron; Laura Alcazar-Fuoli; Emilia Mellado; Maria J Buitrago; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

6.  In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa.

Authors:  Yali Li; Zhe Wan; Ruoyu Li
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 7.  A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.

Authors:  E Forestier; V Remy; O Lesens; M Martinot; Y Hansman; B Eisenmann; D Christmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-05       Impact factor: 3.267

8.  In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii.

Authors:  Houmin Li; Jianjun Qiao; Zhe Wan; Jianzhong Zhang
Journal:  Mycopathologia       Date:  2010-12-14       Impact factor: 2.574

9.  Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.

Authors:  Dominique M Vandijck; Dominique D Benoit; Pieter O Depuydt; Fritz C Offner; Stijn I Blot; Anna K Van Tilborgh; Joke Nollet; Eva Steel; Lucien A Noens; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

10.  Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations.

Authors:  Laura Bedin Denardi; Jéssica Tairine Keller; Maria Isabel de Azevedo; Vanessa Oliveira; Fernanda Baldissera Piasentin; Cecília Bittencourt Severo; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Mycopathologia       Date:  2017-10-09       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.